Clinical Trials Directory

Trials / Completed

CompletedNCT02468050

Study of Exercise to Manage Distress During Breast Screening

Effectiveness of Exercise Training and Self Management in the Attenuation of Anxiety and Depressive Symptoms Following Breast Biopsy

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
7 (actual)
Sponsor
University of Western Ontario, Canada · Academic / Other
Sex
Female
Age
18 Years – 69 Years
Healthy volunteers
Not accepted

Summary

The breast cancer screening and diagnostic period is associated with heightened symptoms of anxiety and depression. Physical exercise has been found to effectively decrease these symptoms in healthy and diseased populations. This study aims to determine if a pre treatment exercise intervention can minimize symptoms of anxiety and depression in women undergoing screening for breast cancer.

Detailed description

The breast cancer diagnostic process is associated with anxiety and depression. Physical exercise has emerged as an attractive non-pharmacologic approach to mitigating the psychological and physical sequelae of breast cancer and its treatments, however pre treatment interventions are not integrated into current practice. This study aims to determine the effectiveness and feasibility of a pre treatment exercise intervention in attenuating levels of anxiety and depression following breast biopsy and throughout the diagnostic period.

Conditions

Interventions

TypeNameDescription
BEHAVIORALModerate intensity exercise training6 weeks of moderate intensity exercise training (50 - 75% of heart rate reserve). Sessions are facility and home based and include cardiovascular warm-up, cardiovascular training, muscular conditioning, and flexibility exercises.
BEHAVIORALSelf Management of exerciseIn addition to the 6 week exercise program (refer to Exercise Treatment Group), participants randomly assigned to the Self Management Group will learn strategies for the self management of exercise.

Timeline

Start date
2012-02-01
Primary completion
2014-02-01
Completion
2014-02-01
First posted
2015-06-10
Last updated
2015-06-10

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT02468050. Inclusion in this directory is not an endorsement.